September 2022 - Page 18 of 26

WednesdaySep 14, 2022 10:00 am

Freight Technologies Inc. (NASDAQ: FRGT) Marks Milestone Intended to Foster Company Growth

Freight Technologies is an emerging growth company whose unique solutions suite is designed to optimize and automate the supply chain process and provide a platform for B2B cross-border shipping in North America The company recently filed Form F-1 with the SEC registering more than 19 million ordinary shares for resale by selling shareholders identified in the registration statement CEO Javier Selgas hailed the milestone as a move that positions the company to continue to work with the capital markets to foster company growth The filing comes amid favorable market reports that evidence resurgence of the truck freight market in North…

WednesdaySep 14, 2022 9:30 am

Cepton, Inc. (NASDAQ: CPTN) Remains Committed to Delivering Enhanced Safety for All Drivers; Works with Top 10 Global Automotive OEMs to Commercialize Lidar

Evidence suggests that current ADAS solutions relying on cameras for perception are not yet safe enough due to camera’s limited capabilities of providing accurate perception data 24/7 In a recent article authored for Forbes, Cepton's co-founder and CEO Jun Pei calls for widespread adoption of sensor suites that include complementary technologies–including lidar, camera, and radar–that seamlessly work together to enhance safety for drivers Cepton remains committed to deploying lidar in all vehicles with the goal of making the driving experience safer and more efficient for all road participants; expands collaboration with Koito to extend beyond its current OEM series production…

WednesdaySep 14, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Strengthens Board of Directors to Boost Efforts toward Regulatory Approval of Potential Treatment for Hypertension

Lexaria Bioscience is a global innovator in drug delivery platforms whose lead technology, DehydraTECH, has been shown to increase the bioavailability of APIs The company recently announced that Catherine Turkel, PharmD, Ph.D., has joined its board of directors Dr. Turkel, who brings over 20 years’ experience, has previously formulated Food and Drug Administration (“FDA”) registration and commercial strategic plans, as well as led global development programs for pharmaceutical and biologic treatments Dr. Turkel will lend her drug registration experience and regulatory expertise to Lexaria at a time when the company is journeying toward regulatory approval for DehydraTECH-CBD, its drug candidate…

TuesdaySep 13, 2022 3:17 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) ASR Patrols Portland Hotel, Augments 24/7 Security

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has deployed another of its proprietary K5 Autonomous Security Robot (“ASR”) to bolster security efforts at a hotel in Portland, Oregon. According to the announcement, the KSCP robot is patrolling the Aloft Hotel area amid security staffing challenges as well as ongoing theft and vandalism problems. The client reached out to Knightscope to arrange for ASR surveillance. As a result, KSCP deployed the robot, which the client dubbed Robby, to provide 24/7 surveillance. Utilizing Knightscope’s technology, Robby informs hotel staff whenever any suspicious activity…

TuesdaySep 13, 2022 2:49 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Participation at H. C. Wainwright Annual Global Investment Conference

Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide life sciences, nutraceuticals, cosmetics, food and beverage, and other key industries. The company today announced its participation in the H. C. Wainwright Annual Global Investor Conference taking place from Sept. 12-14, 2022. This conference features a number of exciting, rapidly growing public and private companies, presenting for 30 minutes each. During PBI’s presentation, which took place live beginning at 1:30 p.m. ET on Sept. 13, the company’s President and CEO Richard T. Schumacher…

TuesdaySep 13, 2022 1:13 pm

QualityStocksNewsBreaks – D-Wave Quantum Inc.’s (NYSE: QBTS) Trailblazing Efforts in Quantum Market Featured in Bell2Bell Podcast

D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services, was featured in the Bell2Bell Podcast, a part of IBN’s (“InvestorBrandNetwork”) sustained effort to provide specialized content distribution via widespread syndication channels. Dr. Alan Baratz, CEO of D-Wave, joined the latest episode to introduce D-Wave and discuss its position as a trailblazer in quantum computing. “D-Wave is the first and only commercial quantum computing company. While everybody else in the quantum space is talking about government research grants as revenue, and national labs and academic institutions as customers, we talk about companies like Mastercard, PayPal, Johnson & Johnson,…

TuesdaySep 13, 2022 12:57 pm

QualityStocksNewsBreaks – REZYFi Inc. Engages IBN for Corporate Communications Expertise

REZYFi, a cannabis-focused mortgage origination and specialized financing company, has selected the corporate communications expertise of IBN, a multifaceted financial news and publishing company for private and public entities. As part of the client partner relationship, IBN will leverage its investor based distribution network of 5,000+ key syndication outlets, various newsletters, social media channels, wire services via InvestorWire, blogs and other outreach tools to build greater awareness for REZYFi. “REZYFi is taking charge as one of first cannabis mortgage bankers in the U.S., while most traditional lenders are still hesitant to serve the unique and evolving needs of the state-licensed…

TuesdaySep 13, 2022 12:47 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Moves to Complete Key Acquisition, Bring Proven Success into Northeast Renewables Market

Correlate Infrastructure Partners (OTCQB: CIPI), a technology-enabled energy optimization and clean energy solutions provider for all North America, today announced a nonbinding letter of intent to acquire Vermont-based Aegis Renewable Energy Inc. A member of the Amicus Solar Cooperative Network, Aegis is a leading commercial, industrial and community solar company focused on solar project development and EPC (engineering, procurement, construction) services in the eastern United States. Completion of the acquisition will provide Correlate with strategic abilities to capitalize on the burgeoning Northeast renewable energy market. Todd Michaels, Correlate’s CEO and president, said of the move: “Upon completion of this key…

TuesdaySep 13, 2022 12:39 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Recognized for Strategic M&A Objectives at Benzinga Cannabis Capital Conference

Flora (NASDAQ: FLGC) is a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands. The company today announced its receipt of the Best M&A Deal award at Benzinga’s 2022 Cannabis Capital Conference in Chicago. “We are honored to receive the award for Best M&A Deal at the Benzinga Cannabis Capital Conference, which recognizes our strategic M&A objectives including acquiring products, expertise, expanding distribution, and customers,” said Luis Merchan, chairman and CEO of Flora. To view the full press release, visit https://ibn.fm/NKcW7 About Flora Growth Corp. Flora is building a connected, design-led collective of plant-based wellness and lifestyle…

TuesdaySep 13, 2022 12:30 pm

QualityStocksNewsBreaks – Odyssey Health Inc. (ODYY) Reports Successful Safety Outcomes for Most Recent Phase of Concussion Drug Trial

Odyssey Health (OTC: ODYY), formerly Odyssey Group International and a company focused on developing unique, life-saving medical products, has completed the safety measures for the second cohort of its phase I multiday ascending dosing (“MAD”) clinical trial. According to the announcement, the trial is designed to evaluate the company’s novel drug to treat concussion: PRV-002. During the trial, healthy human subjects received the drug in order to determine its safety; for all cohorts of the trial, PRV-002 was found to be safe and was well tolerated. The company stated that during phase 1 of the MAD trial, 16 trial participants…

Site Search

Company Search

Month: September 2022